COVID-19 Research
The Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes the COVID-19 respiratory disease. SARS-CoV-2 is highly contagious and transmits predominantly via the respiratory route. It is an enveloped virus with a single-stranded RNA genome. Small molecules can be used to investigate the virus and the corresponding immune response. Researchers can save up to 50% on high purity Covid-19 research products - they are up to half the price of other suppliers.
View products: Compound repurposing | Virus attachment / entry | Viral replication | Cytokine storm | Organoids | Cell culture reagents | Cell stains, viability & proliferation | CRISPR / gene editing
Amisulpride (HB1879)
Description:Potent, selective dopamine D2 and D3 receptor antagonist. Atypical antipsychotic.
Purity:>98%
- Description:
Fluorescent D1 dopamine receptor antagonist
-
Dihydroergocristine mesylate (HB1611)
Description:5-HT antagonist. Also partial agonist at adrenergic and dopaminergic receptors.
Purity:>98%
-
Haloperidol hydrochloride (HB1842)
Description:Dopamine receptor antagonist with partial D2-like selectivity
Purity:>99%
-
Olanzapine (HB1786)
Description:5-HT2A and D2 antagonist. Potent DREADD agonist. Atypical antipsychotic.
Purity:>99%
-
Prochlorperazine dimaleate (HB1907)
Description:D2 receptor antagonist. Also 5-HT3 and nAChR antagonist.
Purity:>99%
-
Quetiapine hemifumarate (HB1803)
Description:5-HT2 and D2 antagonist. Atypical antipsychotic.
Purity:>99%
![CA200773 CellAura fluorescent D<sub>1</sub> antagonist [SKF83566-green]](https://cdn.hellobio.com/media/catalog/product/cache/7630ee9852b6c22c7de1165054afc779/h/b/hb7822-ca200773-image1_1.png)
